Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2011. Start Trial.
Date Value
September 30, 2026 85.67%
August 31, 2026 85.67%
July 31, 2026 85.67%
June 30, 2026 85.67%
May 31, 2026 85.67%
April 30, 2026 85.67%
March 31, 2026 85.67%
February 28, 2026 85.67%
January 31, 2026 85.67%
December 31, 2025 85.67%
November 30, 2025 85.67%
October 31, 2025 85.67%
September 30, 2025 85.67%
August 31, 2025 85.67%
July 31, 2025 85.67%
June 30, 2025 85.67%
May 31, 2025 85.67%
April 30, 2025 85.67%
March 31, 2025 85.67%
February 28, 2025 85.67%
January 31, 2025 85.67%
December 31, 2024 85.67%
November 30, 2024 85.67%
October 31, 2024 85.67%
September 30, 2024 85.67%
Date Value
August 31, 2024 85.67%
July 31, 2024 76.27%
June 30, 2024 70.10%
May 31, 2024 70.10%
April 30, 2024 70.10%
March 31, 2024 70.10%
February 29, 2024 70.10%
January 31, 2024 70.10%
December 31, 2023 70.10%
November 30, 2023 70.10%
October 31, 2023 70.10%
September 30, 2023 70.10%
August 31, 2023 70.10%
July 31, 2023 70.10%
June 30, 2023 72.46%
May 31, 2023 74.39%
April 30, 2023 74.39%
March 31, 2023 76.94%
February 28, 2023 76.94%
January 31, 2023 76.94%
December 31, 2022 76.94%
November 30, 2022 76.94%
October 31, 2022 76.94%
September 30, 2022 76.94%
August 31, 2022 76.94%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Viatris, Inc. 81.23%
Johnson & Johnson 18.44%
Liquidia Corp. 92.71%
Organon & Co. 82.70%
ANI Pharmaceuticals, Inc. 72.96%